Meiling Ji
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in ⓘ
- Oncology 26
- Colorectal Cancer Treatments and Studies 9
- Cancer Immunotherapy and Biomarkers 7
-
- RNA modifications and cancer 7
- Co-authors
- Guodong He (22 shared papers)Jianmin Xu (20 shared papers)Ye Wei (24 shared papers)Wenju Chang (23 shared papers)Dexiang Zhu (24 shared papers)Qingyang Feng (21 shared papers)Li Ren (19 shared papers)Liangliang Yang (5 shared papers)
- Journals
- Cancer Management and Research (3 papers)Journal of Clinical Oncology (3 papers)OncoTargets and Therapy (2 papers)Journal of Translational Medicine (2 papers)Annals of Surgical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Meiling Ji
50 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 111
- Cancer Research 351
- Oncology 324
- Immunology 191
- Molecular Biology 527
- Pulmonary and Respiratory Medicine 217
Countries citing papers authored by Meiling Ji
This map shows the geographic impact of Meiling Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Ji more than expected).
Fields of papers citing papers by Meiling Ji
This network shows the impact of papers produced by Meiling Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Ji. The network helps show where Meiling Ji may publish in the future.
Co-authors
The 25 scholars most cited alongside Meiling Ji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 136 | |
| 2 | 2019 | 104 | |
| 3 | 2016 | 94 | |
| 4 | 2018 | 87 | |
| 5 | 2020 | 60 | |
| 6 | 2018 | 60 | |
| 7 | 2016 | 45 | |
| 8 | 2022 | 44 | |
| 9 | 2023 | 40 | |
| 10 | 2016 | 34 | |
| 11 | 2022 | 26 | |
| 12 | 2016 | 25 | |
| 13 | 2018 | 24 | |
| 14 | 2017 | 21 | |
| 15 | 2018 | 20 | |
| 16 | 2022 | 19 | |
| 17 | 2019 | 19 | |
| 18 | CCR7 high expression leads to cetuximab resistance by cross-talking with EGFR pathway in PI3K/AKT signals in colorectal cancer. | 2019 | 19 |
| 19 | 2019 | 18 | |
| 20 | 2016 | 17 |
About Meiling Ji
Meiling Ji is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 50 papers that have together received 1.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), RNA modifications and cancer (7 papers), Ferroptosis and cancer prognosis (7 papers), Genetic factors in colorectal cancer (5 papers), Cancer-related molecular mechanisms research (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Cancer Research (351 citations), Oncology (324 citations), Immunology (191 citations), Molecular Biology (527 citations) and Pulmonary and Respiratory Medicine (217 citations). Meiling Ji has collaborated with scholars based in China, United States and France. Frequent co-authors include Guodong He, Jianmin Xu, Ye Wei, Wenju Chang, Dexiang Zhu, Qingyang Feng, Li Ren, Liangliang Yang, Wentao Tang and Yihao Mao. Their work appears in journals such as Cancer Management and Research, Journal of Clinical Oncology, OncoTargets and Therapy, Journal of Translational Medicine and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.